SANTEN PHARMACEUTICAL CO.,LTD. 4536Short Interest
No institution currently reports a short position of 0.5% or more in SANTEN PHARMACEUTICAL CO.,LTD. (4536). The last disclosure was on 2026-09-24 (Barclays Capital Securities Ltd, 0.45%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
131 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 9 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2018-07-04 |
|---|---|
| Latest disclosure | 2026-09-24 (Barclays Capital Securities Ltd, 0.45%) |
| Reporting institutions | 9 firms (131 reports) |
| Peak estimated short interest | 2.79% (2022-05-25, 2 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Integrated Core Strategies (Asia) Pte. Ltd.
- J.P. MORGAN SECURITIES PLC
- Barclays Capital Securities Ltd
- Diversified Select Opportunities Capital Management, LLC
- BNP Paribas Arbitrage SNC
- Others
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-04-21 | J.P. MORGAN SECURITIES PLC | Position 1,603,168 shares | Ratio 0.49% | ▼0.26% | Below 0.5% |
| 2024-06-06 | GOLDMAN SACHS INTERNATIONAL | Position 1,781,838 shares | Ratio 0.48% | ▼0.02% | Below 0.5% |
| 2024-08-07 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 1,740,468 shares | Ratio 0.47% | ▼0.03% | Below 0.5% |
| 2026-09-24 | Barclays Capital Securities Ltd | Position 1,475,452 shares | Ratio 0.45% | ▼0.05% | Below 0.5% |
| 2022-05-26 | Diversified Select Opportunities Capital Management, LLC | Position 1,780,500 shares | Ratio 0.44% | ▼0.15% | Below 0.5% |
| 2019-10-03 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,048,542 shares | Ratio 0.26% | ▼1.22% | Below 0.5% |
| 2022-09-12 | BNP Paribas Arbitrage SNC | Position 1,047,968 shares | Ratio 0.26% | ▼0.44% | Below 0.5% |
| 2025-08-28 | JPM Securities Japan Co Ltd. | Position 873,229 shares | Ratio 0.25% | ▼0.32% | Below 0.5% |
| 2026-04-13 | Barclays Bank PLC | Position 701,500 shares | Ratio 0.21% | ▼0.29% | Below 0.5% |
Disclosure History 131 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-09-24 | Barclays Capital Securities Ltd | Position 1,475,452 shares | Ratio 0.45% | ▼0.05% | Below 0.5% |
| 2026-09-18 | Barclays Capital Securities Ltd | Position 1,619,552 shares | Ratio 0.50% | ▼0.12% | — |
| 2026-09-16 | Barclays Capital Securities Ltd | Position 2,017,581 shares | Ratio 0.62% | ▲0.05% | — |
| 2026-09-07 | Barclays Capital Securities Ltd | Position 1,861,481 shares | Ratio 0.57% | ▼0.12% | — |
| 2026-09-02 | Barclays Capital Securities Ltd | Position 2,232,081 shares | Ratio 0.69% | ▼0.04% | — |
| 2026-08-28 | Barclays Capital Securities Ltd | Position 2,379,158 shares | Ratio 0.73% | ▲0.36% | — |
| 2026-08-20 | Barclays Capital Securities Ltd | Position 1,560,101 shares | Ratio 0.48% | ▼0.09% | Below 0.5% |
| 2026-08-07 | Barclays Capital Securities Ltd | Position 1,867,045 shares | Ratio 0.57% | ▼0.05% | — |
| 2026-08-06 | Barclays Capital Securities Ltd | Position 2,015,345 shares | Ratio 0.62% | ▲0.03% | — |
| 2026-08-03 | Barclays Capital Securities Ltd | Position 1,908,445 shares | Ratio 0.59% | ▼0.02% | — |
| 2026-07-28 | Barclays Capital Securities Ltd | Position 1,977,745 shares | Ratio 0.61% | ▲0.11% | — |
| 2026-07-23 | Barclays Capital Securities Ltd | Position 1,617,545 shares | Ratio 0.50% | ▲0.08% | — |
| 2026-07-07 | Barclays Capital Securities Ltd | Position 1,165,871 shares | Ratio 0.36% | ▼0.21% | Below 0.5% |
| 2026-07-03 | Barclays Capital Securities Ltd | Position 1,867,271 shares | Ratio 0.57% | ▼0.08% | — |
| 2026-06-30 | Barclays Capital Securities Ltd | Position 2,119,071 shares | Ratio 0.65% | ▼0.12% | — |
| 2026-06-25 | Barclays Capital Securities Ltd | Position 2,508,871 shares | Ratio 0.77% | ▼0.09% | — |
| 2026-06-19 | Barclays Capital Securities Ltd | Position 2,798,871 shares | Ratio 0.86% | ▼0.06% | — |
| 2026-06-17 | Barclays Capital Securities Ltd | Position 2,977,471 shares | Ratio 0.92% | ▲0.10% | — |
| 2026-06-15 | Barclays Capital Securities Ltd | Position 2,655,348 shares | Ratio 0.82% | ▲0.10% | — |
| 2026-06-11 | Barclays Capital Securities Ltd | Position 2,340,448 shares | Ratio 0.72% | ▲0.05% | — |
| 2026-06-08 | Barclays Capital Securities Ltd | Position 2,182,448 shares | Ratio 0.67% | ▼0.05% | — |
| 2026-06-04 | Barclays Capital Securities Ltd | Position 2,342,586 shares | Ratio 0.72% | ▼0.06% | — |
| 2026-06-03 | Barclays Capital Securities Ltd | Position 2,662,648 shares | Ratio 0.82% | ▲0.04% | — |
| 2026-06-02 | Barclays Capital Securities Ltd | Position 2,535,248 shares | Ratio 0.78% | ▼0.08% | — |
| 2026-06-01 | Barclays Capital Securities Ltd | Position 2,773,448 shares | Ratio 0.86% | ▲0.10% | — |
| 2026-05-29 | Barclays Capital Securities Ltd | Position 2,456,448 shares | Ratio 0.76% | ▲0.13% | — |
| 2026-05-27 | Barclays Capital Securities Ltd | Position 2,042,939 shares | Ratio 0.63% | ▲0.13% | — |
| 2026-05-25 | Barclays Capital Securities Ltd | Position 1,623,500 shares | Ratio 0.50% | ▲0.06% | — |
| 2026-04-21 | J.P. MORGAN SECURITIES PLC | Position 1,603,168 shares | Ratio 0.49% | ▼0.26% | Below 0.5% |
| 2026-04-17 | J.P. MORGAN SECURITIES PLC | Position 2,447,231 shares | Ratio 0.75% | ▲0.25% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |